This site is not optimized for Internet Explorer 8 (or older).

Please upgrade to a newer version of Internet Explorer or use an alternate browser such as Chrome or Firefox.

FDA Panel: Engineered Donor Heart Valves Need PMA

Tuesday, October 14, 2014

Submitted by


Shannon Firth

More than minimally manipulated (MMM) allograft heart valves should be classified as high risk devices, requiring premarket approval including safety and efficacy studies, according to an FDA panel. 

Add comment

Log in or register to post comments